Company record
Grimann S.A. de C.V.
1 FDA warning letter since 2023 and 0 recalls in the last 12 months.
Get an email the day FDA posts anything new about Grimann S.A. de C.V..
Warning letters
-
DrugsGrimann S.A. de C.V.
FDA warns Grimann over Derofen Miel drug listing with contradictory active ingredients, label image, and package size.
Low